Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

Update Il y a 4 ans
Reference: NCT00607451

Woman and Man

  • | Country :
  • Israel
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine the safety, tolerability, pharmacokinetic and pharmacodynamic effects of single doses of Neu-120 in Parkinson's disease patients with levodopa-induced dyskinesia.


Inclusion criteria

  • Levodopa Induced Dyskinesia

Links